The Potentially Modifiable Risk Factor in Idiopathic Intracranial Hypertension
Body Weight
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 24, 2020
- Accepted January 6, 2021
- First Published March 3, 2021.
Article Versions
- Previous version (March 3, 2021 - 06:21).
- You are viewing the most recent version of this article.
Author Disclosures
- Susan P. Mollan, FRCOphth,
- Abd A. Tahrani, PhD and
- Alexandra J. Sinclair, PhD
- Susan P. Mollan, FRCOphth,
Janssen Neurodiem Invex therapeutics
NONE
Heidelberg Engineering, speaker honoraria
NONE
NONE
Neuro-Ophthalmology: Global Trends in Diagnosis, Treatment and Management. Springer, 2019.
NONE
NONE
Heidelberg Engineering, speaker bureau
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Abd A. Tahrani, PhD and
Novo Nordisk Eli Lilly BI
NONE
Eli Lilly, Janssen, AZ, BI, NAPP, MSD, Novo Nordisk
Associate Editor for the European Journal of Endocrinology Senior Editor BMC Endocrine Disorders
NONE
NONE
NONE
Novo Nordisk, Eli Lilly, BI, Sanofi, AZ
Novo Nordisk, Eli Lilly, NAPP, AZ, BI, MSD, Sanofi,
Impeto Medical Resmed Aptiva
NONE
The URGO Foundation
National Institute for Health Research UK
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alexandra J. Sinclair, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) NIHR Clinician Scientist Fellowship (NIHR-CS-011-028) 2) Medical Research Council, UK (MR/K015184/1).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Birmingham Neuro-Ophthalmology (SPM), Queen Elizabeth Hospital; Institute of Metabolism and Systems Research (AAT), College of Medical and Dental Sciences, University of Birmingham; Department of Diabetes and Endocrinology (AAT), Queen Elizabeth Hospital, Birmingham; Metabolic Neurology (AJS), Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham; and Department of Neurology (AJS), University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, United Kingdom.
- Correspondence
Ms. Mollan soozmollan{at}doctors.org.uk
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.